Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis

被引：0
|
作者：
Ian Naya
Lee Tombs
David A. Lipson
Isabelle Boucot
Chris Compton
机构：
[1] Global Respiratory Franchise,Perelman School of Medicine
[2] GSK,undefined
[3] Precise Approach Ltd,undefined
[4] contingent worker on assignment at GSK,undefined
[5] Respiratory Research and Development,undefined
[6] GSK,undefined
[7] University of Pennsylvania,undefined
来源：
Respiratory Research | / 20卷
关键词：
COPD; Maintenance therapy; Exacerbation risk; ICS; Long acting bronchodilators; Lung function;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Impact of Prior and Concurrent Medication on Exacerbation Risk with Long-Acting Bronchodilators in Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
    Naya, I.
    Lipson, D. A.
    Boucot, I.
    Gakava, L.
    Compton, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [2] Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis
    Naya, Ian
    Tombs, Lee
    Lipson, David A.
    Boucot, Isabelle
    Compton, Chris
    RESPIRATORY RESEARCH, 2019, 20
  • [3] Cost-effectiveness of long-acting bronchodilators for chronic obstructive pulmonary disease
    Oba, Yuji
    MAYO CLINIC PROCEEDINGS, 2007, 82 (05) : 575 - 582
  • [4] Long acting bronchodilators in chronic obstructive pulmonary disease
    Griffiths, I
    NEW ZEALAND MEDICAL JOURNAL, 1997, 110 (1054) : 402 - 403
  • [5] Double-edged Sword?: Long-Acting Bronchodilators in Chronic Obstructive Pulmonary Disease
    Woodruff, Prescott G.
    JAMA INTERNAL MEDICINE, 2013, 173 (13) : 1184 - 1185
  • [6] Cardiovascular Safety of Inhaled Long-Acting Bronchodilators in Individuals With Chronic Obstructive Pulmonary Disease
    Gershon, Andrea
    Croxford, Ruth
    Calzavara, Andrew
    To, Teresa
    Stanbrook, Matthew B.
    Upshur, Ross
    Stukel, Therese A.
    JAMA INTERNAL MEDICINE, 2013, 173 (13) : 1175 - 1184
  • [7] Long-Acting Bronchodilators and Risk of Adverse Cardiovascular Events in Chronic Obstructive Pulmonary Disease: A Focused Critical Review
    Tao, Sunning
    Kirsch, Erika
    Yeomans, Karen
    Sigler, Catherine
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 456 - 457
  • [8] Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease
    Wang, Meng-Ting
    Lai, Jyun-Heng
    Tsai, Chen-Liang
    Liou, Jun-Ting
    JOURNAL OF FOOD AND DRUG ANALYSIS, 2019, 27 (03) : 657 - 670
  • [9] LONG-ACTING BRONCHODILATORS AND RISK OF ADVERSE CARDIOVASCULAR EVENTS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A FOCUSED CRITICAL REVIEW
    Tao, S.
    Kirsch, E.
    Yeomans, K.
    Sigler, C.
    VALUE IN HEALTH, 2015, 18 (03) : A169 - A169
  • [10] How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?
    Beeh, Kai M.
    Burgel, Pierre-Regis
    Franssen, Frits M. E.
    Luis Lopez-Campos, Jose
    Loukides, Stelios
    Hurst, John R.
    Flezar, Matjaz
    Ulrik, Charlotte Suppli
    Di Marco, Fabiano
    Stolz, Daiana
    Valipour, Arschang
    Casserly, Brian
    Stallberg, Bjorn
    Kostikas, Konstantinos
    Wedzicha, Jadwiga A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (02) : 139 - 149
12345